{
    "code": "01057134",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057134",
    "time": "2016-12-09 03:17:39",
    "許可證字號": "衛署藥製字第057134號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/03\/13",
    "發證日期": "101\/03\/13",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105713400",
    "中文品名": "&quot;台耀&quot;拿帕蒂",
    "英文品名": "Lapatinib Ditosylate",
    "適應症": "在和capecitabine併用的情況下，TYKERB適用於治療腫瘤有HER2 (ErbB2)過度表現之現象且曾接受anthracycline、taxane以及trastuzumab治療後病況惡化之後期或轉移性乳癌患者。在和芳香西每抑制劑(aromatase inhibitor)併用的情況下，TYKERB適用於治療Her2\/neu (ErbB2)過度表現，荷爾蒙接受體呈陽性之轉移性乳癌患者，但未曾接受過trastuzumab或芳香西每抑制劑治療，且目前不打算進行化療之停經後婦女。",
    "劑型": "041粉劑",
    "包裝": "0.5公斤以上紙桶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "主成分略述": [
        ""
    ],
    "限制項目": "03外銷專用",
    "申請商名稱": "620102G419  台耀化學股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "6132051075  台耀化學股份有限公司蘆竹廠",
        "製造廠廠址": "桃園市蘆竹區坑口村和平街36、36-1號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "F154 Lapatinib Ditosylate標籤DOH-Eng___20120827.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057134&Seq=001&Type=8"
        }
    ]
}